Memorial Sloan Kettering Cancer Center

MSK Experts To Receive Prestigious Awards at the American Association for Cancer Research (AACR) 2023 Annual Meeting

April 14, 2023 · Breaking News

Newswise — Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate…

FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center

November 1, 2022 · Breaking News

Newswise — Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic®) for the treatment of adult…